UTA biology professor awarded NIH grant for new super-resolution microscope

When Disc Med­i­cine closed a $62.5 mil­lion raise led by Bain Cap­i­tal ear­li­er this year, the biotech’s CEO John Quisel point­ed to the stream of

In the absence of PCR testing, infectious disease experts and epidemiologists are anxiously awaiting serology results from the household contact and two healthcare workers who

Res­o­nance Med­i­cine, a two-year-old stealth-stage biotech out of the lab of famed bio­chemist David Liu, has de­cid­ed to shut down, End­points News has learned. The